A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/16418882

Download in:

View as

General Info

PMID
16418882